Single cell formulation set-up to ‘efficiently deliver RNA vaccines’

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ktsimage)
(Image: Getty/ktsimage)

Related tags: Rna, Biologics, Vaccines, formulation, lipid

Dolomite’s high throughput, single cell encapsulation set-up aims to accelerate delivery of RNA vaccines.

The single cell encapsulation set-up, Dolomite uEncapsulator, is used to focus on vaccine delivery by incorporating self-amplifying RNA with lipids, which allows the RNA to determine cellular uptake and protein expression.

A spokesperson for Dolomite told us, “The liposomal formulations consist of a cationic lipid (usually either DDA or DOTAP), and a phospholipid such as DOPE and cholesterol.”

By incorporating a cationic lipid in the liposome, the formulation is able to “efficiently deliver RNA vaccines”​ that are more biocompatible compared with other delivery vehicles, the spokesperson further explained.

To create the formulation, the Dolomite uEncapsulator produces liposomes in large batches and then mixes the liposomes with RNA.

According to Dolomite, the set-up can vary flow rates of the mixing stream and temperature, which enables precise size control of the liposomes.

The set-up is currently used at Imperial College London for the development of RNA vaccines in liposomal formulations, targeting diseases such as HIV, influenza, rabies and chlamydia.

Related news

Related products

show more

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Nifty Biosimilar

Nifty Biosimilar

UGA Biopharma | 13-Mar-2018 | Research Study

Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Related suppliers

Follow us


View more